Executive Summary
Patients with AIDS or HIV infection are more susceptible to specific cancer types than those without HIV infection and they often have a recurrence of particular cancer types referred to as AIDS-associated cancer. AIDS-associa...
Executive Summary
Approximately 36.7 million people have been affected by HIV infection. NHL is generally the most common type of cancer among HIV-infected patients, while the incidence of Kaposi’s sarcoma is rare. Out of the 36.7 million popul...
Executive Summary
Risk factors influence the chance of developing cancer among individuals, but individuals with no risk factors also develop cancer. Various traditional cancer risk factors such as oncogenic viral infection, smoking, etc., and im...
Executive Summary
The prevention from HIV associated cancer include beneficial effects of cART on HIV replication, inflammation, and immune function. The screening of HPV associated malignancies is carried out to reduce the risk of HIV associate...
Executive Summary
HIV or AIDS-related cancer is diagnosed based particularly on the symptoms. Moreover, the signs and symptoms of HIV or AIDS-associated cancer experienced by the individuals help understanding the medical problem. Some of the HIV...
Executive Summary
Different tests are available for HIV-associated diagnosis development. Diagnosis of Kaposi's sarcoma includes various tests such as histopathological examinations, fecal occult blood test, endoscopy or colonoscopy, bronchoscopy...
Executive Summary
The stage of cancer (including HIV associated cancer) indicates the tumor size and the spread of the cancer cells from the site of origin. The grade indicates the microscopic appearance of the cancer cells. A TNM staging system ...
Executive Summary
Treatment recommendations depend upon the size, grade and type of tumor, metastasis, possible side effects, and patient’s (HIV Associated Cancer) preferences and overall health. The common treatment for HIV associated cancer i...
Executive Summary
Clinical trials are a better method for treating HIV associated cancer. Most clinical trials are not specific to HIV and cancer patients, and most clinical trials have historically excluded HIV infected patients. This makes it c...
Executive Summary
Several latest research studies have been progressing to seek more information on HIV-associated cancer, related prevention methods, diagnostic process at the initial phase, and best treatment strategies. Recent research studies...
Executive Summary
The HIV-associated cancer treatments result in causing various side effects and changes to the body of the patient. The results of treatment show variations among the patients. Sometimes the same treatment strategy used for a pa...
Executive Summary
Follow-up care for HIV-associated cancer refers to the after-treatment protocols conducted by the healthcare team to look after recurrence, manage the side effects, and monitor the overall health of the patient. The constant loo...
Executive Summary
Cancer mortality among HIV-infected people with cancer has declined over time, but these deaths account for an increasing fraction of all deaths. In fact, approximately 6% of HIV-infected patients developed malignancies, and abo...
Patients with HIV and cancer should often talk with the doctors and members of the health care team to help them better understand the cancer diagnosis, the cancer treatment regime, and post-treatment follow-up care. The patients may ask the doctors...
